Why Are Analysts Bullish about Humana (NYSE:HUM) Stock?
Shares of health insurance and well-being company Humana (NYSE:HUM) have remained resilient to the sharp selloff in the equities this year. It is trading in the green, compared to the 19% decline in the SP 500 (SPX) Index. Other than its ability to defend its market share, the company''s durable earnings and strong visibility over future growth keep Wall Street analysts bullish on HUM stock. Humana Projects Strong Earnings Growth During the recently held virtual Investor Day, Humana raised its Fiscal 2022 earnings outlook. It expects to deliver adjusted earnings of approximately $25, up from the previous guidance of $24.75. Furthermore, the new earnings forecast reflects solid 21% year-over-over growth.
Why Are Analysts Bullish about Humana (NYSE:HUM) Stock?
Shares of health insurance and well-being company Humana (NYSE:HUM) have remained resilient to the sharp selloff in the equities this year. It is trading in the green, compared to the 19% decline in the SP 500 (SPX) Index. Other than its ability to defend its market share, the company''s durable earnings and strong visibility over future growth keep Wall Street analysts bullish on HUM stock. Humana Projects Strong Earnings Growth During the recently held virtual Investor Day, Humana raised its Fiscal 2022 earnings outlook. It expects to deliver adjusted earnings of approximately $25, up from the previous guidance of $24.75. Furthermore, the new earnings forecast reflects solid 21% year-over-over growth.